EU ‘Structured Dialog’ Offers Opportunity To Secure Supply
Industry Calls For Policies, Investment And Regulation To Support Manufacturing
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
